Carboplatin, 5-fluorouracil and folinic acid in advanced and recurrent squamous carcinoma of the head and neck
โ Scribed by Junor, EJ; Canney, PA; Symonds, RP
- Book ID
- 123476041
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 171 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt
## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi